Effectiveness of Different Surgical Techniques for Curative Treatment of Pilonidal Sinus Disease in the Pediatric Population (PiloPedia)

March 9, 2026 updated by: University Hospital, Angers

Effectiveness of Different Surgical Techniques for Curative Treatment of Pilonidal Sinus Disease in the Pediatric Population: A 10-Year Single-Center Retrospective Comparative Cohort Study

Pilonidal sinus disease (PSD) in children is associated with significant morbidity and recurrence risk. Multiple surgical techniques are used, including excision with open healing, primary midline closure, off-midline closure, flap reconstruction, and minimally invasive approaches. However, high-quality comparative data in pediatric populations are limited, and adult data cannot be directly extrapolated.

This single-center retrospective cohort study aims to compare the effectiveness of different surgical techniques used for curative treatment of PSD in children treated at CHU Angers between January 1, 2015 and March 31, 2025.

The primary endpoint is surgical failure at 2 months, defined as absence of complete wound healing or early recurrence. Secondary outcomes include postoperative complications, time to healing, pain outcomes, length of hospital stay, and recurrence at 1 year.

Results are expected to help optimize institutional management strategies and contribute to pediatric-specific evidence.

Study Overview

Detailed Description

This is a single-center retrospective observational cohort study conducted in the Departments of Pediatric Surgery and Visceral Surgery at CHU Angers, France.

All consecutive patients under 18 years of age who underwent surgical treatment for pilonidal sinus disease between January 1, 2015 and March 31, 2025 will be included.

Surgical techniques analyzed include:

  • Wide excision with open healing
  • Wide excision with primary midline closure
  • Wide excision with primary midline closure and negative pressure wound therapy
  • Minimally invasive/endoscopic techniques The primary objective is to compare treatment effectiveness at 2 months postoperatively. Secondary objectives include comparison of complication rates, healing delay, postoperative pain, and recurrence at 1 year, as well as identification of predictive factors for recurrence.

Data will be extracted from medical records and anonymized prior to statistical analysis.

Study Type

Observational

Enrollment (Estimated)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Pediatric population

Description

Inclusion Criteria:

  • Age < 18 years at time of surgery
  • Surgical treatment for pilonidal sinus disease
  • Surgery performed between January 1, 2015 and March 31, 2025
  • Managed at CHU Angers (Pediatric or Visceral Surgery departments)
  • ICD-10 diagnosis code L05.9
  • CCAM procedure code QBFA007

Exclusion Criteria:

  • Emergency incision and drainage of acute pilonidal abscess (CCAM QBPA001)
  • Initial surgical management performed at another institution
  • Refusal of participation (patient and/or legal guardians, if applicable)
  • Alternative diagnosis (anal abscess, gluteal abscess)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Wide excision with open healing
Intentional traditional treatment whitch consists in wide excision of the pilonidal sinus, and progressive healing of the wound thanks to daily dressing changes until complete closure is obtained.
curative treatment of pilonidal sinus, consisting in a wide excision followed by open healing or direct closure of the wound +/- negative pressure therapy dressing. Alterantivelly, an endoscopic procedure to destroy the pilonidal sinus can be performed.
Wide excision with primary midline closure
Alternative technique using an immediate closure of the wound with layer of stiches, and regular dressings
curative treatment of pilonidal sinus, consisting in a wide excision followed by open healing or direct closure of the wound +/- negative pressure therapy dressing. Alterantivelly, an endoscopic procedure to destroy the pilonidal sinus can be performed.
Wide excision with primary midline closure and negative pressure wound therapy
Alternative technique using an immediate closure of the wound with layer of stiches, completed with negative pressure therapy dressing, allowing for a fater recovery while requiring less dressing survey and changes.
curative treatment of pilonidal sinus, consisting in a wide excision followed by open healing or direct closure of the wound +/- negative pressure therapy dressing. Alterantivelly, an endoscopic procedure to destroy the pilonidal sinus can be performed.
Minimally invasive/endoscopic techniques
Surgical treatment for pilonidal sinus disease, including various techniques including excision with or without primary closure, or endoscopic techniques.
curative treatment of pilonidal sinus, consisting in a wide excision followed by open healing or direct closure of the wound +/- negative pressure therapy dressing. Alterantivelly, an endoscopic procedure to destroy the pilonidal sinus can be performed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Failure rate
Time Frame: 2 months after surgery

Definition of failure:

  • Absence of complete wound healing at 2 months, OR
  • Clinical recurrence of pilonidal sinus within 2 months
2 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative complications
Time Frame: Up to 1 year
  • Early (<30 days) and late complications
  • Graded according to Clavien-Madadi classification Through study completion, average 6 month
Up to 1 year
Time to complete wound healing
Time Frame: Up to 1 year
time in months
Up to 1 year
Length of hospital stay
Time Frame: at hospital discharge
duration of hospital stay in days
at hospital discharge
Postoperative pain duration
Time Frame: Up to 30 days
Up to 30 days
Postoperative pain Intensity
Time Frame: Up to 30 days
Up to 30 days
Analgesic consumption for postoperative pain
Time Frame: Up to 30 days
morphine equivalent dose
Up to 30 days
Predictive factors for recurrence
Time Frame: Up to last follow-up
bivariate and multivariate analysis
Up to last follow-up
Recurrence rate
Time Frame: Up to 1 year
Through study completion, average 6 month
Up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Françoise SCHMITT, University hospital of Angers

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Study Registration Dates

First Submitted

March 4, 2026

First Submitted That Met QC Criteria

March 9, 2026

First Posted (Actual)

March 13, 2026

Study Record Updates

Last Update Posted (Actual)

March 13, 2026

Last Update Submitted That Met QC Criteria

March 9, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sacrococcygeal Pilonidal Sinus

Clinical Trials on Surgical treatment for pilonidal sinus disease, including various techniques including excision with or without primary closure, or endoscopic techniques.

Subscribe